-
Posted by
Two Blokes 6 hours ago -
Filed in
Stock
-
0 views
AI is revolutionizing healthcare, with Recursion Pharmaceuticals leveraging AI and vast datasets for drug discovery, making it a compelling investment opportunity. Recursion's integrated drug discovery platform, partnerships with major pharma companies, and significant data resources, position it for growth despite current financial challenges. The FDA's shift towards AI-based models for preclinical drug development could provide Recursion with a strong tailwind, reducing costs and accelerating timelines.
